Concepedia

Edith Langevin

EL

Statistics

Publications

11

Citations

3K

H-Index

10

Active since

2014

Affiliations

Sanofi (France)(Current)

Sanofi (United States)

Institut Pasteur de Montevideo

Fred Hutch Cancer Center

Asociación Colombiana de Facultades de Ingeniería

Edith Langevin is an author at Sanofi (France) specializing in veterinary medicine, infectious diseases, and vaccination.

Publications per year

2014–2022

11

Publications

11

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

Maria Rosario Capeding, Ngoc Huu Tran, Sri Rezeki Hadinegoro et al. · The Lancet · 2014 · 969 citations

, , +17

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

Luis Villar, Gustavo H. Dayan, José Luis Arredondo-Garcı́a et al. · New England Journal of Medicine · 2014 · 942 citations · Full text

, , +17

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

Saranya Sridhar, Alexander R. Luedtke, Edith Langevin et al. · New England Journal of Medicine · 2018 · 789 citations · Full text

, , +16

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials

Michal Juraska, Craig A. Magaret, Jason Shao et al. · Proceedings of the National Academy of Sciences · 2018 · 83 citations · Full text

, , +17

Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America

Sri Rezeki Hadinegoro, Humberto Reynales, Mary Noreen Chua et al. · Clinical Microbiology and Infection · 2018 · 67 citations · Full text

, , +17

1–5 of 11